Assessment of Protein Kinase C mRNA Levels in Alzheimer's Disease Brains

この論文にアクセスする

この論文をさがす

著者

抄録

We have previously demonstrated that the protein level of type β protein kinase C (PKC) was significantly reduced in Alzheimer''s disease (AD) brains compared to controls. To clarify whether this is due to decreased synthesis and/or increased degradation of PKC, the present study was performed to examine mRNA levels of PKC isozymes in control and AD brains. The present study indicated that mRNA levels of types α, β and γ PKC were not significantly changed in the control and AD brains. Thus, the reduction of type β PKC protein content in AD brains might be caused by increased degradation.

収録刊行物

  • The Japanese journal of pharmacology

    The Japanese journal of pharmacology 71(2), 175-177, 1996-06

    The Japanese Pharmacological Society

参考文献:  7件中 1-7件 を表示

各種コード

  • NII論文ID(NAID)
    10008188714
  • NII書誌ID(NCID)
    AA00691188
  • 本文言語コード
    ENG
  • 資料種別
    SHO
  • ISSN
    00215198
  • データ提供元
    CJP書誌  J-STAGE 
ページトップへ